Andrew Cooper Analyst PerformanceVice President Life Science Tools & Services, Diagnostics & Clinical Laboratories at Raymond James FinancialAndrew Cooper is a stock analyst at Raymond James Financial in the healthcare sector, covering 18 publicly traded companies. Over the past year, Andrew Cooper has issued 13 stock ratings, including buy and hold recommendations. While full access to Andrew Cooper's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Andrew Cooper's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings45 Last 6 YearsBuy Recommendations90.48% 38 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution42RatingsDistribution of strong buy, buy, hold, and sell ratings by Andrew Cooper.RatingPercentageCount Strong Buy7.1%3 ratings Buy83.3%35 ratings Hold9.5%4 ratings Sell0.0%0 ratingsOut of 42 total stock ratings issued by Andrew Cooper at Raymond James Financial, the majority (83.3%) have been Buy recommendations, followed by 9.5% Hold and 7.1% Strong Buy.Best & Worst CallsBest Call0000.0%GHJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BIORAug 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ61.1% of companies on NASDAQ11 companiesNYSE38.9% of companies on NYSE7 companiesAndrew Cooper, an analyst at Raymond James Financial, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare18 companies100.0%Andrew Cooper of Raymond James Financial specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES6 companies33.3%LIFE SCIENCES TOOLS & SERVICES5 companies27.8%HEALTHCARE EQUIPMENT & SUPPLIES4 companies22.2%BIOTECHNOLOGY2 companies11.1%PHARMACEUTICALS1 company5.6% About Andrew CooperAndrew Cooper joined Raymond James in June 2013 and the equity research team in June 2014 in the healthcare space. In February 2020 he assumed lead coverage of the diagnostics & clinical laboratories sector, with further expansion into the life science tools industry thereafter. Cooper graduated from the University of North Carolina at Chapel Hill with a bachelor of science in business administration and political science in May of 2013.Follow on LinkedIn Andrew Cooper's Ratings History at Raymond James Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEHCEncompass Health9/28/2026Set Price Target$124.48$150.00$0.0000.00% ROIADUSAddus HomeCare9/28/2026Set Price Target$113.55$137.00$0.0000.00% ROILMRILumexa Imaging9/28/2026Set Price Target$10.00$17.00$0.0000.00% ROIACHCAcadia Healthcare9/28/2026Downgrade$28.09$39.00Outperform$0.0000.00% ROIHAEHaemonetics9/3/2026Boost Price Target$102.41$125.00Outperform$0.0000.00% ROIITGRInteger2/23/2026Reiterated Rating$84.65$101.00Outperform$0.0000.00% ROIAZTAAzenta11/25/2025Boost Price Target$37.92$45.00Outperform$0.0000.00% ROIHAEHaemonetics11/14/2025Reiterated Rating$73.98$90.00Outperform$0.0000.00% ROIFLGTFulgent Genetics11/14/2025Reiterated Rating$29.59$36.00Outperform$0.0000.00% ROIAVTRAvantor11/4/2025Downgrade$11.68Market Perform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ITGRInteger10/24/2025Reiterated Rating$71.94$95.00Outperform$0.0000.00% ROIHOLXHologic10/22/2025Downgrade$73.97Hold$0.0000.00% ROIAVTRAvantor10/16/2025Boost Price Target$14.58$16.00Outperform$0.0000.00% ROIHAEHaemonetics8/11/2025Downgrade$53.88$78.00Outperform$00.0000.00% ROIAZTAAzenta8/6/2025Upgrade$26.90$35.00Outperform$00.0000.00% ROIAVTRAvantor8/4/2025Set Price Target$11.30$14.00Outperform$00.0000.00% ROIGHGuardant Health7/31/2025Boost Price Target$41.34$61.00Outperform$000.0000.00% ROIRVTYRevvity7/29/2025Reiterated Rating$95.66$115.00Outperform$000.0000.00% ROIITGRInteger7/25/2025Lower Price Target$106.48$143.00Outperform$00.0000.00% ROITMOThermo Fisher Scientific7/24/2025Reiterated Rating$479.45$535.00Outperform$000.0000.00% ROIMYGNMyriad Genetics5/7/2025Reiterated Rating$4.79$10.00Outperform$0.0000.00% ROIFLGTFulgent Genetics5/5/2025Reiterated Rating$20.04$25.00Outperform$00.0000.00% ROIHOLXHologic5/2/2025Reiterated Rating$53.21$71.00Outperform$0.0000.00% ROIRVTYRevvity4/29/2025Reiterated Rating$94.90$120.00Outperform$00.0000.00% ROIITGRInteger4/25/2025Boost Price Target$121.61$150.00Outperform$00.0000.00% ROIITGRInteger3/28/2025Initiated Coverage$117.74$145.00Outperform$00.0000.00% ROIUFPTUFP Technologies3/28/2025Initiated Coverage$203.23Market Perform$000.0000.00% ROIMYGNMyriad Genetics2/25/2025Reiterated Rating$11.68$19.00Outperform$0.0000.00% ROIGHGuardant Health2/21/2025Reiterated Rating$44.43$59.00Outperform$000.0000.00% ROIAVTRAvantor2/10/2025Reiterated Rating$18.93$24.00Outperform$00.0000.00% ROIHOLXHologic2/6/2025Reiterated Rating$66.04$90.00Outperform$00.0000.00% ROIDHRDanaher2/3/2025Reiterated Rating$222.56Market Perform$000.0000.00% ROITMOThermo Fisher Scientific2/3/2025Reiterated Rating$598.40$667.00Outperform$000.0000.00% ROIRVTYRevvity2/3/2025Reiterated Rating$126.13$145.00Outperform$000.0000.00% ROIRVTYRevvity1/21/2025Lower Price Target$123.18$140.00Outperform$000.0000.00% ROIDHRDanaher1/21/2025Lower Price Target$244.34$275.00Outperform$000.0000.00% ROIAVTRAvantor1/21/2025Lower Price Target$22.17$26.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageJefferies Financial GroupWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
